A small molecule fibrokinase inhibitor in a model of fibropolycystic hepatorenal disease

about

A small molecule fibrokinase inhibitor in a model of fibropolycystic hepatorenal disease

Item

http://www.wikidata.org/entity/Q57652249

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

A small molecule fibrokinase inhibitor in a model of fibropolycystic hepatorenal disease

@en

A small molecule fibrokinase inhibitor in a model of fibropolycystic hepatorenal disease

@nl

type

Item

label

A small molecule fibrokinase inhibitor in a model of fibropolycystic hepatorenal disease

@en

A small molecule fibrokinase inhibitor in a model of fibropolycystic hepatorenal disease

@nl

prefLabel

A small molecule fibrokinase inhibitor in a model of fibropolycystic hepatorenal disease

@en

A small molecule fibrokinase inhibitor in a model of fibropolycystic hepatorenal disease

@nl

P1476

A small molecule fibrokinase inhibitor in a model of fibropolycystic hepatorenal disease

@en

P2093

Bin Duan

http://www.w3.org/2001/XMLSchema#string

Brian Huang

http://www.w3.org/2001/XMLSchema#string

Itzhak D Goldberg

http://www.w3.org/2001/XMLSchema#string

Jing-Song Li

http://www.w3.org/2001/XMLSchema#string

Latha Paka

http://www.w3.org/2001/XMLSchema#string

Michael A Yamin

http://www.w3.org/2001/XMLSchema#string

Ping Zhou

http://www.w3.org/2001/XMLSchema#string

Prakash Narayan

http://www.w3.org/2001/XMLSchema#string

Prani Paka

http://www.w3.org/2001/XMLSchema#string

Scott L Friedman

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence for a "Pathogenic Triumvirate" in Congenital Hepatic Fibrosis in Autosomal Recessive Polycystic Kidney Disease

An Empirical Biomarker-Based Calculator for Cystic Index in a Model of Autosomal Recessive Polycystic Kidney Disease-The Nieto-Narayan Formula

Directional cell migration and chemotaxis in wound healing response to PDGF-AA are coordinated by the primary cilium in fibroblasts

Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: summary statement of a first National Institutes of Health/Office of Rare Diseases conference

Autosomal recessive polycystic kidney disease: a hepatorenal fibrocystic disorder with pleiotropic effects

Failure to ubiquitinate c-Met leads to hyperactivation of mTOR signaling in a mouse model of autosomal dominant polycystic kidney disease.

Elevated c-myc protooncogene expression in autosomal recessive polycystic kidney disease

ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice.

The role of vascular endothelial growth factor (VEGF) in renal pathophysiology.

Fibropolycystic liver disease: CT and MR imaging findings.

P304

96-107

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5527/WJN.V7.I5.96

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30211028

http://www.w3.org/2001/XMLSchema#string

P932

6134267

http://www.w3.org/2001/XMLSchema#string